The efficacy of the COVID-19 breath analyzer testing device, which is comprised of a nanomaterial-based sensor array, was successfully validated in March 2020 by a preliminary case-control clinical study in Wuhan, China. The study included 49 confirmed COVID-19 patients, 58 healthy controls and 33 non-COVID lung infection controls. COVID-19 patients were sampled twice: during the active disease and after the recovery. Analysis of the results of the test showed great discrimination between the different groups.
The test could significantly reduce transmission of COVID-19 in public spaces, reduce the burden on number of unneeded confirmatory tests and lower the burden on the hospitals, and has the potential to be used in future outbreaks of new diseases in the future.
Source: Israeli developed COVID-19 breath test could be used by public – The Jerusalem Post






You must be logged in to post a comment.